The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Sarcoid-like granulomatosis (endo-/extrathoracic)
Publications
El Jammal T, Jamilloux Y, Gerfaud-Valentin M, Richard-Colmant G, Weber E, Bert A, Androdias G, Sève P
Challenging Mimickers in the Diagnosis of Sarcoidosis: A Case Study.
Diagnostics (Basel, Switzerland) 2021 Jul 12;11; — 2021 Jul 12
Lambert N, Hansen I, El Moussaoui M, Giot JB, Vercheval C, Lommers É, Somja J, Moutschen M, Maquet P
Lung and liver sarcoidosis-like reaction induced by tocilizumab.
British journal of clinical pharmacology 2021 Apr 26;; — 2021 Apr 26
Pérez-De-Lis M, Retamozo S, Flores-Chávez A, Kostov B, Perez-Alvarez R, Brito-Zerón P, Ramos-Casals M
Autoimmune diseases induced by biological agents. A review of 12,731 cases (BIOGEAS Registry).
Expert opinion on drug safety 2017 Nov;16;1255-1271 — 2017 Nov — 1255-1271
Sarcoidosis induced by tocilizumab: a paradoxical event?
The Journal of rheumatology 2013 Oct;40;1773-4 — 2013 Oct — 1773-4